Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Kezar Life Sciences Inc (NQ: KZR ) 0.6500 -0.0050 (-0.76%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Kezar Life Sciences Inc < Previous 1 2 3 4 5 6 Next > The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization September 09, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:... Via Benzinga Exposures COVID-19 Kezar Life Sciences to Participate in Two Upcoming Investor Conferences September 02, 2021 From Kezar Life Sciences, Inc. Via Business Wire The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself September 03, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:... Via Benzinga Kezar Life Sciences Announces Completion of Enrollment of Its Phase 2 PRESIDIO Clinical Trial of KZR-616 in Polymyositis and Dermatomyositis August 23, 2021 From Kezar Life Sciences, Inc. Via Business Wire The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab September 02, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV... Via Benzinga Exposures COVID-19 Product Safety Kezar Life Sciences Reports Second Quarter Financial Results and Provides Business Updates August 12, 2021 From Kezar Life Sciences, Inc. Via Business Wire The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering September 01, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021 July 20, 2021 Upgrades For Bank of Marin Bancorp (NASDAQ: Via Benzinga The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical August 31, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... Via Benzinga Kezar Life Sciences to Participate in the William Blair Biotech Focus Conference 2021 July 08, 2021 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences Announces Formation of Clinical Advisory Committee June 08, 2021 From Kezar Life Sciences, Inc. Via Business Wire 12 Health Care Stocks Moving In Wednesday's After-Market Session June 02, 2021 Gainers Tilray (NASDAQ:TLRY) shares incre... Via Benzinga The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements June 02, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) Anika Therapeutics, Inc. (... Via Benzinga Exposures Product Safety Kezar Presents Results of the Completed MISSION Phase 1b Study of KZR-616 at EULAR 2021 June 02, 2021 From Kezar Life Sciences, Inc. Via Business Wire Kezar Appoints Rheumatology Industry Expert, Micki Klearman, MD, to its Board of Directors June 01, 2021 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences to Participate in the Jefferies Virtual Healthcare Conference May 27, 2021 From Kezar Life Sciences, Inc. Via Business Wire The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes May 31, 2021 After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-... Via Benzinga Exposures Product Safety Kezar Life Sciences to Host Virtual MISSION Phase 1b Data Update Call at EULAR 2021 on June 2, 2021 May 26, 2021 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences Reports First Quarter Financial Results and Provides Business Updates May 12, 2021 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences Recognized as 2021 Bay Area Best Places to Work May 10, 2021 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences Presents Preclinical Data with IND Candidate KZR-261 at American Association for Cancer Research (AACR) 2021 Virtual Annual Meeting April 10, 2021 From Kezar Life Sciences, Inc. Via Business Wire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.